277
Participants
Start Date
September 12, 2018
Primary Completion Date
November 4, 2021
Study Completion Date
November 4, 2021
V114
15-valent pneumococcal conjugate vaccine with serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F (2 mcg each), serotype 6B (4 mcg) and Merck Aluminum Phosphate Adjuvant (125 mcg) in each 0.5 mL dose.
Prevnar 13™
13-valent pneumococcal conjugate vaccine with serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F (2.2 mcg) and 6B (4.4 mcg), and aluminum phosphate adjuvant (125 mcg aluminum) in each 0.5 ml dose
PNEUMOVAX™23
23-valent pneumococcal polysaccharide vaccine with serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F (25 mcg each) in each 0.5 mL dose
Cliniques Universitaires Saint-Luc ( Site 0122), Brussels
St. Vincent's Hospital ( Site 0041), Sydney
The Children s Hospital at Westmead ( Site 0191), Westmead
UZ Leuven ( Site 0119), Leuven
The Alfred Hospital ( Site 0037), Melbourne
Royal Melbourne Hospital ( Site 0039), Parkville
Austin Health-Austin Hospital ( Site 0038), Heidelberg
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0121), Liège
Royal Adelaide Hospital ( Site 0040), Adelaide
AZ Sint Jan Brugge-Oostende ( Site 0118), Bruges
AZ Delta ( Site 0120), Roeselare
Montefiore Einstein Center ( Site 0164), The Bronx
Hospital Espanol ( Site 0059), México
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0058), Mexico City
Instituto Nacional de Cancerologia. ( Site 0060), México
Johns Hopkins - University ( Site 0023), Baltimore
Hopital Jean Minjoz Besancon ( Site 0085), Besançon
University of Florida ( Site 0011), Gainesville
CHU de Grenoble Hopital Nord ( Site 0083), La Tronche
Universitaetsklinikum Duesseldorf ( Site 0107), Düsseldorf
Cleveland Clinic Foundation ( Site 0168), Cleveland
Cincinnati Children's Hospital Medical Center ( Site 0010), Cincinnati
Indiana Blood and Marrow Transplantation ( Site 0001), Indianapolis
Universitaetsklinikum Koeln ( Site 0105), Cologne
Universitaetsmedizin Mainz ( Site 0106), Mainz
CHRU de Lille - Hopital Claude Huriez ( Site 0090), Lille
University of Chicago ( Site 0016), Chicago
Children's Mercy Hospital ( Site 0167), Kansas City
Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0187), Monterrey
Servicio de hematologia Universidad Autonoma de Nuevo Leon ( Site 0057), Monterrey
University of Kansas Medical Center ( Site 0007), Kansas City
Hopital Saint-Antoine ( Site 0089), Paris
Baylor College of Medicine - Texas Children's Hospital ( Site 0165), Houston
Children's Hospital Colorado ( Site 0166), Aurora
CHU Henri Mondor ( Site 0081), Créteil
Stanford Health Care ( Site 0005), Palo Alto
Oregon Health & Science University ( Site 0018), Portland
Fundacion Valle del Lili ( Site 0073), Santiago de Cali
Centro Medico Imbanaco de Cali S.A ( Site 0075), Santiago de Cali
Hospital Sao Rafael ( Site 0049), Salvador
Santa Casa de Misericordia de Belo Horizonte ( Site 0050), Belo Horizonte
Instituto de Cancer e Transplante de Curitiba ICTR ( Site 0051), Curitiba
Nova Scotia Health Authority QEII-HSC ( Site 0033), Halifax
Juravinski Cancer Centre ( Site 0032), Hamilton
CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0031), Montreal
Hospital Pablo Tobon Uribe ( Site 0077), Medellín
CHU de Nice ( Site 0084), Nice
Instituto Nacional de Pediatria ( Site 0062), Mexico City
Hospital Infantil de Mexico Federico Gomez ( Site 0061), Mexico City
Karolinska Universitetssjukhuset ( Site 0143), Stockholm
Akademiska Sjukhuset ( Site 0144), Uppsala
Sahlgrenska Universitetssjukhuset ( Site 0145), Gothenburg
Merck Sharp & Dohme LLC
INDUSTRY